| Literature DB >> 30542636 |
Edward Florez1, Todd Nichols1, Ellen E Parker1, Seth T Lirette1, Candace M Howard1, Ali Fatemi2.
Abstract
Purpose The definition of radiotherapy target volume is a critical step in treatment planning for all tumor sites. Conventional magnetic resonance imaging (MRI) pulse sequences are used for the definition of the gross target volume (GTV) and the contouring of glioblastoma multiforme (GBM) and meningioma. We propose the use of multiparametric MRI combined with radiomic features to improve the texture-based differentiation of tumor from edema for GTV definition and to differentiate vasogenic from tumor cell infiltration edema. Methods Twenty-five patients with brain tumor and peritumoral edema (PTE) were assessed. Of the enrolled patients, 17 (63 ± 10 years old, six female and 11 male patients) were diagnosed with GBM and eight (64 ± 14 years old, five female and three male patients) with meningioma. A 3 Tesla (3T) MRI scanner was used to scan patients using a 3D multi-echo Gradient Echo (GRE) sequence. After the acquisition process, two experienced neuroradiologists independently used an in-house semiautomatic algorithm to conduct a segmentation of two regions of interest (ROI; edema and tumor) in all patients using functional MRI sequences, apparent diffusion coefficient (ADC), and dynamic contrast-enhanced MRI (DCE-MRI), as well as anatomical MRI sequences-T1-weighted, T2-weighted and fluid-attenuated inversion recovery (FLAIR). Radiomic (computer-extracted texture) features were extracted from all ROIs through different approaches, including first-, second-, and higher-order statistics, both with and without normalization, leading to the calculation of around 300 different texture parameters for each ROI. Based on the extracted parameters, a least absolute shrinkage and selection operator (LASSO) analysis was used to isolate the parameters that best differentiated edema from tumors while irrelevant parameters were discarded. Results and conclusions The parameters chosen by LASSO were used to perform statistical analyses which allowed identification of the variables with the best discriminant ability in all scenarios. Receiver operating characteristic results showcase both the best single discriminator and the discriminant capacity of the model using all variables selected by LASSO. Excellent results were obtained for patients with GBM with all MRI sequences, with and without normalization; a T1-weighted sequence postcontrast (T1W+C) with normalization offered the best tumor classification (area under the curve, AUC > 0.97). For patients with meningioma, a good model of tumor classification was obtained through the T1-weighted sequence (T1W) without normalization (AUC > 0.71). However, there was no agreement between the results of both radiologists for some MRI sequences analyzed for patients with GBM and meningioma. In conclusion, a small subset of radiomic features showed an excellent ability to distinguish edema from tumor tissue through its most discriminating features.Entities:
Keywords: big data; intracranial tumors; mri multiparametric sequences; peritumoral edema; radimic texture features
Year: 2018 PMID: 30542636 PMCID: PMC6284876 DOI: 10.7759/cureus.3426
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Features of glioblastoma and meningioma, two common primary intracranial tumors with a high incidence in adult patients
WHO: World Health Organization
| Description | Principal Glial Tumor GLIOBLASTOMA | Principal Meningeal Tumor MENINGIOMA |
| Incidence of occurrence | 12% - 20% of all brain tumors | 14% - 19% of all brain tumors |
| Age propensity | 45 - 65 years | 35 - 70 years |
| Sex propensity | Almost 2:1 male preponderancea | Almost 2:1 female preponderance |
| Expected locations | Frontal, frontomedial, frontolateral, frontodorsal, temporal, temporomedial including basal ganglia, temporo-parieto-occipital, corpus callosum (butterfly glioma), occipital region, supratentorial | Parasagittal region, falx, convexity, entire skull base, posterior fossa, tentorium, lateral ventricles |
| WHO grade classification | IV | I, II (atypical) or III (papillary or anaplastic) |
|
Louis et al. [ | ||
Figure 1Flow chart with the sequence of modules used in this study: (a) different MRI pulse sequences from patients diagnosed with primary intracranial tumor, (b) contouring process of tumor and edema, (c) radiomic (computer-extracted texture) features extraction, (d) statistical reduction and selection of parameters with the best discriminant ability for distinguishing tumors from edema, and (e) statistical assessment
ADC: apparent diffusion coefficient; DCE: dynamic contrast-enhanced; FLAIR: fluid-attenuated inversion recovery; GLCM: gray level co-occurrence matrix; GLRLM: gray-level run-length matrix; LASSO: least absolute shrinkage and selection operator; MRI: magnetic resonance imaging; T2-W: T2-weighted
Patient demographic information and brain tumor characteristics according to the tumor's grade
GBM: glioblastoma multiforme; SD: standard deviation; WHO: World Health Organization
| Numbers (%) | WHO grade I | WHO grade II | WHO grade III | WHO grade IV | |
| All patients enrolled | 25 | ||||
| GBM | 17 (68) | 0 | 0 | 0 | 17 |
| Meningioma | 8 (32) | 3 | 3 | 2 | 0 |
| Gender | |||||
| Male | 14 (56) | 0 | 0 | 0 | 14 |
| Female | 11 (44) | 3 | 3 | 2 | 3 |
| Age | |||||
| Mean ± SD | 65 ± 12 | 50 ± 11 | 71 ± 7 | 77 ± 2 | 63 ± 10 |
| Tumor Size | |||||
| Maximum Length (cm) | 4.2 ± 1.2 | 4.7 ± 0.8 | 4.2 ± 0.7 | 3.9 ± 1.1 | 4.1 ± 1.4 |
| Area (cm2) | 9.8 ± 5.3 | 9.5 ± 6.1 | 12.1 ± 4.2 | 8.9 ± 5.1 | 9.5 ± 5.7 |
| Location | |||||
| Covexity | 7 (28) | 0 | 0 | 0 | 7 (28) |
| Parasagittal | 5 (20) | 0 | 0 | 0 | 5 (20) |
| Skull base | 3 (12) | 0 | 0 | 0 | 3 (12) |
| Posterior fossa | 2 (8) | 0 | 0 | 0 | 2 (8) |
| Frontodorsal | 4 (16) | 1 (4) | 2 (8) | 1 (4) | 0 |
| Corpus callosum | 2 (8) | 1 (4) | 0 | 1 (4) | 0 |
| Supratentorial | 2 (8) | 0 | 2 (8) | 0 | 0 |
Figure 2The study used images acquired for each enrolled patient using five different MRI pulse sequences: (a) FLAIR; (b) ADC; (c) T2-W; (d) and (e) DCE pre- and postcontrast, respectively
ADC: apparent diffusion coefficient; DCE: dynamic contrast-enhanced; FLAIR: fluid-attenuated inversion recovery; MRI: magnetic resonance imaging; T2-W: T2-weighted
Figure 3Segmentation process applied to the five different MRI sequences used in the study: (a) original image; (b) FLAIR; (c) ADC; (d) T2-W and DCE; (e) precontrast and (f) postcontrast
ADC: apparent diffusion coefficient; DCE: dynamic contrast-enhanced; FLAIR: fluid-attenuated inversion recovery; MRI: magnetic resonance imaging; T2-W: T2-weighted
Figure 4Radiomic features used in this study were distributed in three different techniques focused primarily on statistical approaches: (a) first-order statistics, (b) second-order statistics through the GLCM, and (c) higher-order statistics through the GLRLM
ADC: apparent diffusion coefficient; FLAIR: fluid-attenuated inversion recovery; GLCM: gray-level co-occurrence matrix; GLCMT: gray-level co-occurrence matrix transpose; GLRLM: gray-level run-length matrix; L: length of homogeneous runs for each grey level; ROI: region of interest; T1W: T1-weighted precontrast; T1W+C: T1-weighted postcontrast; T2W: T2-weighted
Set of parameters selected by LASSO procedure involving two expert neuroradiologists. The selection includes the radiomic features with the best discriminant ability to differentiate edema from tumor tissue for different MRI sequences, different primary tumoral disease and different scenarios
ADC: apparent diffusion coefficient; d: distance between the pixel of interest and its neighbor; FLAIR: fluid-attenuated inversion recovery; GLCM: gray-level co-occurrence matrix; GLRLM: gray-level run-length matrix; LASSO: least absolute shrinkage and selection operator; MRI: magnetic resonance imaging; NA: no agreement; T1W: T1-weighted precontrast; T1W+C: T1-weighted postcontrast; T2W: T2-weighted
| Sequence | Parameter(s) | Most Useful Parameter* | ||
| Meningioma | Non-normalized | ADC | GLCM Correlation, 90°, d = 1; GLCM Sum Average, 90°, d = 1; GLCM Sum Average, 45°, d = 1; Histogram Skewness | GLCM Sum Average, 90°, d = 1; GLCM Sum Average, 45°, d = 1b |
| FLAIR | Histogram Percentile 90% | Histogram Percentile 90%d | ||
| T1W | GLRLM Gray-Level Non-Uniformity 0°; Histogram Skewness | Histogram Skewness | ||
| T1W+C | GLCM Difference Entropy, 135°, d = 4; Histogram Percentile 99% | Histogram Percentile 99%e | ||
| T2W | Histogram Percentile 1%; Histogram Percentile 50%; Histogram Skewness | Histogram Percentile 1%; Histogram Percentile 50%f | ||
| Normalized | ADC | None Selectedc | NAc | |
| FLAIR | None Selectedc | NAc | ||
| T1W | None Selectedc | NAc | ||
| T1W+C | Histogram Percentile 99% | Histogram Percentile 99%e | ||
| T2W | GLCM Sum Average, 135°, d = 5; GLRLM Gray-Level Non-Uniformity 90°; Histogram Percentile 1%; Histogram Percentile 50% | Histogram Percentile 1%; Histogram Percentile 50%f | ||
| Glioblastoma | Non-normalized | ADC | GLCM Entropy, 135°, d = 5 | GLCM Entropy, 135°, d = 5 |
| FLAIR | None Selectedc | NAc | ||
| T1W | None Selectedc | NAc | ||
| T1W+C | GLCM Correlation, 135°, d = 2 | GLCM Correlation, 135°, d = 2 | ||
| T2W | GLCM Entropy, 135°, d = 5; Histogram Kurtosis; Histogram Percentile 99% | GLCM Entropy, 135°, d = 5 | ||
| Normalized | ADC | GLCM Difference Entropy, 135°, d = 5; GLCM Sum Variance, 90°, d = 3 | GLCM Difference Entropy, 135°, d = 5 | |
| FLAIR | GLCM Sum Average, 45°, d = 5; GLCM entropy, 0°, d = 1; Histogram Percentile 1% | GLCM Entropy, 0°, d = 1 | ||
| T1W | Absolute Gradient Skewness | Absolute Gradient Skewness | ||
| T1W+C | Absolute Gradient Skewness; GLCM Difference Entropy, 0°, d = 5; Histogram Percentile 99% | GLCM Difference Entropy, 0°, d = 5 | ||
| T2W | GLCM Entropy, 135°, d = 5 | GLCM Entropy, 135°, d = 5 | ||
| Defined as a parameter with the best ability to discriminate tumor from edema within each tumor type | ||||
| GLCM Sum Average, 90°, d = 1 or GLCM Sum Average, 45°, d = 1 < 130 perfectly classifies tumor for meningioma, non-normalized ADC sequence | ||||
| No agreement between readers for LASSO results | ||||
| Histogram Percentile 90% < 520 perfectly classifies tumor for meningioma, non-normalized FLAIR sequence | ||||
| Histogram Percentile 99% > 600 perfectly classifies tumor for meningioma, non-normalized, or normalized T1W+C sequence | ||||
| Histogram Percentile 1% < 500 or Histogram Percentile 50% < 600 perfectly classifies tumor for meningioma, non-normalized, or normalized T2W sequence | ||||
AUCs for the most useful parameter for classifying tumors in patients diagnosed with GBM
ADC: apparent diffusion coefficient; AUC: area under the curve; CI: confidence interval; d: distance between the pixel of interest and its neighbor; FLAIR: fluid-attenuated inversion recovery; GBM: glioblastoma multiforme; GLCM: gray level co-occurrence matrix; NA: no agreement; T1W: T1-weighted precontrast; T1W+C: T1-weighted postcontrast; T2W: T2-weighted
| Sequence | Parameter With Best Discriminant Ability | AUC (95% CI) | |
| Non-normalized | ADC | GLCM entropy, 135°, d = 5 | 0.91 (0.85-0.98) |
| FLAIR | None Selecteda | NAa | |
| T1W | None Selecteda | NAa | |
| T1W+C | GLCM Correlation, 135°, d = 2 | 0.85 (0.75-0.94) | |
| T2W | GLCM Entropy, 135°, d = 5 | 0.91 (0.83-0.98) | |
| Normalized | ADC | GLCM Difference Entropy, 135°, d = 5 | 0.90 (0.81-0.98) |
| FLAIR | GLCM Entropy, 0°, d = 1 | 0.82 (0.73-0.92) | |
| T1W | Absolute Gradient Skewness | 0.69 (0.56-0.82) | |
| T1W+C | GLCM Difference Entropy, 0°, d = 5 | 0.99 (0.97-1.00) | |
| T2W | GLCM Entropy, 135°, d = 5 | 0.85 (0.75-0.94) | |
| No agreement between readers for LASSO results | |||
Areas under the curve (AUCs) for the most useful parameter for classifying tumors in patients diagnosed with meningioma
ADC: apparent diffusion coefficient; AUC: area under the curve; CI: confidence interval; d: distance between the pixel of interest and its neighbor; FLAIR: fluid-attenuated inversion recovery; GLCM: gray level co-occurrence matrix; NA: no agreement; PC: perfect classification; T1W: T1-weighted precontrast; T1W+C: T1-weighted postcontrast; T2W: T2-weighted
| Sequence | Parameter With Best Discriminant Ability | AUC (95% CI) | |
| Non-normalized | ADC | GLCM Sum Average, 0°, d = 1 & GLCM Sum Average, 45°, d = 1 < 130 | PCb |
| FLAIR | Histogram 90% < 520 | PCb | |
| T1W | Histogram skewness | 0.85 (0.71-0.99) | |
| T1W+C | Histogram 99% > 600 | PCb | |
| T2W | Histogram 1% & Histogram 50% < 500 | PCb | |
| Normalized | ADC | None Selecteda | NAa |
| FLAIR | None Selecteda | NAa | |
| T1W | None Selecteda | NAa | |
| T1W+C | Histogram 99% > 600 | PCb | |
| T2W | Histogram 1% & Histogram 50% < 500 | PCb | |
| No agreement between readers for LASSO results | |||
| Perfect classification given conditions of the third column | |||
Figure 5AUCs for the most useful parameter for discriminating tumors in patients diagnosed with GBM using (a)-(c) MRI sequences without normalization and (d)-(h) MRI sequences with normalization. Some scenarios have no AUC value since no parameters were chosen by LASSO
ADC: apparent diffusion coefficient; AUC: area under the curve; FLAIR: fluid-attenuated inversion recovery; GBM: glioblastoma multiforme; GLCM: gray level co-occurrence matrix; LASSO: least absolute shrinkage and selection operator; MRI: magnetic resonance imaging; T1W: T1-weighted precontrast; T1W+C: T1-weighted postcontrast; T2W: T2-weighted
Figure 6Sorted values for the best discriminator stratified by tissue (edema and tumor) for different MRI sequences in patients with (a) meningioma without normalization, (b) GBM with normalization, and (c) for specific types of edema linked to patients diagnosed with meningioma and GBM
ADC: apparent diffusion coefficient; FLAIR: fluid-attenuated inversion recovery; GBM: glioblastoma multiforme; GLCM: gray level co-occurrence matrix; MRI: magnetic resonance imaging; T1W: T1-weighted precontrast; T1W+C: T1-weighted postcontrast; T2W: T2-weighted